Active	Status	Sponsor type	Region	Phase	Filter
9 Active 1 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Couñago, Felipe
URONCOR 06-24, NCT05781217 / 2021-006975-41: Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624	Recruiting	3	534	Europe	triptorelin, goserelin, leuprorelin	Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic, GICOR	Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence, Androgen Deprivation Therapy, Metastases-free Survival	12/23	12/32
SABRE, NCT04905069: Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy	Recruiting	N/A	500	Europe, US, RoW	SpaceOAR Vue System	Boston Scientific Corporation	Prostate Cancer	04/27	04/30
Palaniappan, Nachi
SABRE, NCT04905069: Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy	Recruiting	N/A	500	Europe, US, RoW	SpaceOAR Vue System	Boston Scientific Corporation	Prostate Cancer	04/27	04/30
Shelan, Mohamed
SAKK 01/18, NCT03937843: Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma	Active, not recruiting	2	135	Europe	Carboplatin, Cisplatin, Etoposide	Swiss Group for Clinical Cancer Research, German Testicular Cancer Study Group	Seminoma, Testicular Cancer	12/26	12/46
HypoFocal SRT, NCT05746806: Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy	Recruiting	N/A	36	Europe	Ultrahypofractionated salvage radiotherapy to a local recurrence after radical prostatectomy, Androgen deprivation therapy	Insel Gruppe AG, University Hospital Bern, University of Bern, Debiopharm International SA, Werner und Hedy Berger-Janser - Stiftung	Recurrent Prostate Cancer	09/25	08/27
SABRE, NCT04905069: Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy	Recruiting	N/A	500	Europe, US, RoW	SpaceOAR Vue System	Boston Scientific Corporation	Prostate Cancer	04/27	04/30
Mikropoulos, Christos
SABRE, NCT04905069: Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy	Recruiting	N/A	500	Europe, US, RoW	SpaceOAR Vue System	Boston Scientific Corporation	Prostate Cancer	04/27	04/30
Lustenberger, Jens
HypoFocal SRT, NCT05746806: Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy	Recruiting	N/A	36	Europe	Ultrahypofractionated salvage radiotherapy to a local recurrence after radical prostatectomy, Androgen deprivation therapy	Insel Gruppe AG, University Hospital Bern, University of Bern, Debiopharm International SA, Werner und Hedy Berger-Janser - Stiftung	Recurrent Prostate Cancer	09/25	08/27
SABRE, NCT04905069: Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy	Recruiting	N/A	500	Europe, US, RoW	SpaceOAR Vue System	Boston Scientific Corporation	Prostate Cancer	04/27	04/30